Articles by George Koroneos, Online Content & News Editor - Pharmaceutical Executive

ADVERTISEMENT

Articles by George Koroneos, Online Content & News Editor

George Koroneos, Online Content & News Editor


Articles
FDA to Weigh In on Obesity Drug
July 14, 2010

Vivus's weight-loss drug Qnexa is heading into an FDA review with the backing of generally positive study data. Will FDA give the thumbs up? Depends on how severe it thinks the side effects are.

Rx Sales Jump 5.1 Percent to $300 Billion in 2009
April 1, 2010

IMS Health reports a nice increase in prescription sales from 2008 to 2009, even with a recession in full swing. That said, numbers are still well below the historic sales of a few years back, and it's anyone's guess if they will reach that high again.

Two Drugs Fail in Trials
March 10, 2010

Monday was a gloomy day for industry as two separate drug trials went belly up. AstraZeca's Recentin proved that it wasn't up-to-snuff compared with Avastin, and the Roche/Biogen Idec arthritis collaboration treatment, ocrelizumab, may have led to fatalities.

FDA Gives Red Light to Ranbaxy for Generic Flomax
March 3, 2010

The Indian generic firm Ranbaxy was dealt another blow this week as its version of the enlarged prostate drug Flomax was denied approval in the US just as it was about to go to market.

Wyeth Purchase Boosts Pfizer Profits
February 3, 2010

Pfizer's strategy to use Wyeth's drug pipeline to increase its sales has paid off as the drug giant announced that its fourth quarter earnings nearly doubled year-to-year. Too bad investors are running in fear of an ugly 2010 forecast.

UCB-sponsored PatientsLikeMe Site is Live
January 27, 2010

All eyes are on PatientsLikeMe's new epilepsy site. The social network is backed by UCB, but the pharma firm is taking a hands-off approach. Is this the future of pharma social media?

Witty Opens GSK Library for Free Access to Malaria Research
January 20, 2010

GlaxoSmithKline announced that it would open up its library of prospective molecules and investigational vaccines. This move gives researchers free access to study experimental treatments for illnesses that plague the world's poorest countries.

FDA Basics Brings the Agency Out of the Closet
January 13, 2010

The push for government transparency continues with Phase I of FDA's plan to expose the inner workings of that secretive cabal known as the Food and Drug Association. First up, fancy new FAQs.

GAO Seeks Price Spike Explanation
January 13, 2010

At time when people can't even get a 3 percent cost-of-living increase, how can pharma justify price hikes pushing 500 percent (in some categories). A new study by the government's General Accountability Office examines why drug products took a massive price leap in recent years.

ADVERTISEMENT

Click here